Gene · 10481
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circ-ABCC4 contributes to prostate cancer progression and radioresistance by mediating miR-1253/SOX4 cascade. | Anticancer Drugs | 2023 | 36539368 | PubTator, text mining | PubMed |
| Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo-ECAG) ovarian study. | Mol Genet Genomic Med | 2023 | 36537080 | PubTator, text mining | PubMed |
| CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer. | J Clin Oncol | 2023 | 36493335 | PubTator, text mining | PubMed |
| Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics. | Bioact Mater | 2023 | 36471724 | PubTator, text mining | PubMed |
| GeneFriends: gene co-expression databases and tools for humans and model organisms. | Nucleic Acids Res | 2023 | 36454018 | PubTator, text mining | PubMed |
| Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes. | Cancer Discov | 2023 | 36399432 | PubTator, text mining | PubMed |
| Biomolecule-functionalized nanoformulations for prostate cancer theranostics. | J Adv Res | 2023 | 36368516 | PubTator, text mining | PubMed |
| Malignant Perivascular Epithelioid Cell Tumor (PEComa) of the Uterus as Part of the Hereditary Cancer Syndrome: A Case Diagnosed with Multiple Malignancies. | Turk Patoloji Derg | 2023 | 36367123 | PubTator, text mining | PubMed |
| Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients. | Bone Marrow Transplant | 2023 | 36195768 | PubTator, text mining | PubMed |
| HOXB13 facilitates hepatocellular carcinoma progression by activating AKT/mTOR signaling pathway. | Ann Hepatol | 2023 | 36179794 | PubTator, text mining | PubMed |
| Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer. | Eur Urol | 2023 | 36115772 | PubTator, text mining | PubMed |
| Somatic mutations reveal complex metastatic seeding from multifocal primary prostate cancer. | Int J Cancer | 2023 | 35880692 | PubTator, text mining | PubMed |
| Long non-coding RNA ESCCAL-1/miR-590/LRP6 signaling pathway participates in the progression of esophageal squamous cell carcinoma. | Cancer Med | 2023 | 35655441 | PubTator, text mining | PubMed |
| Computational Assessment of the Expression-modulating Potential for Non-coding Variants. | Genomics Proteomics Bioinformatics | 2023 | 34890839 | PubTator, text mining | PubMed |
| Targeting calcineurin induces cardiomyocyte proliferation in adult mice. | Nat Cardiovasc Res | 2022 | 39196243 | PubTator, text mining | PubMed |
| Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer. | Endocr Oncol | 2022 | 37435460 | PubTator, text mining | PubMed |
| Prostate cancer screening: Continued controversies and novel biomarker advancements. | Curr Urol | 2022 | 36714234 | PubTator, text mining | PubMed |
| Identification of molecular subtypes and a prognostic signature based on chromatin regulators related genes in prostate cancer. | Front Genet | 2022 | 36704352 | PubTator, text mining | PubMed |
| Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial Breast Cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study. | Genes (Basel) | 2022 | 36672847 | PubTator, text mining | PubMed |
| Radiation in Early-Stage Breast Cancer: Moving beyond an All or Nothing Approach. | Curr Oncol | 2022 | 36661664 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10481/papers?page=19